- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
T
TXMD
Therapeuticsmd Inc
1.15
-0.04-3.36%After Hours: 1.120 -0.03 -2.61%16:35 11/03 EST
OPEN/PREV CLOSE1.170/1.190
TODAY RANGE1.120-1.190
VOL40.76K
MARKET CAP13.31M
52 WEEK RANGE0.7000-2.440
AVG VOL (3M)169.49K
% TURNOVER0.35%
TURNOVER--
P/E (TTM)-28.8945
% RANGE5.88%
EPS(TTM)-0.0398
P/E(FORWARD)7.67
P/B0.4877
BVPS2.358
DIVIDEND--
P/S7.53
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP13.10M
SHARES OUTSTANDING11.57M
NEXT EARNINGS11/10-11/14
FREE FLOAT11.40M
LOT SIZE1
EX-DATE05/09/2022
News
Press Releases
Financial Reports
Profile
Dow Jones·3d ago
TherapeuticsMD Inc. Stock Slips 4.0%, Underperforms Market
Dow Jones·6d ago
TherapeuticsMD Inc. Stock Sheds 4.6%, Underperforms Market
Dow Jones·10/23 20:34
TherapeuticsMD Inc. Stock Climbs 7.4%, Outperforms Market
Dow Jones·10/22 20:34
TherapeuticsMD Inc. Stock Advances 4.3%, Outperforms Market
Dow Jones·10/20 20:33
TherapeuticsMD Inc. Stock Sheds 8.0%, Underperforms Market
Dow Jones·10/17 20:33
TherapeuticsMD Inc. Stock Climbs 19.6%, Outperforms Market
Benzinga·10/06 21:06
12 Health Care Stocks Moving In Monday's After-Market Session
Dow Jones·09/03 20:34
TherapeuticsMD Inc. Stock Advances 4.2%, Outperforms Market
TipRanks·08/22 04:08
TherapeuticsMD Reports Improved Q2 2025 Results
Dow Jones·08/21 20:35
TherapeuticsMD Inc. Stock Slides 2.7%, Underperforms Market
Dow Jones·08/18 20:35
TherapeuticsMD Inc. Stock Sheds 2.6%, Underperforms Market
Simply Wall St·08/18 10:36
TherapeuticsMD Second Quarter 2025 Earnings: EPS: US$0.047 (vs US$0.091 loss in 2Q 2024)
Dow Jones·08/13 20:35
TherapeuticsMD Inc. Stock Advances 5.0%, Outperforms Market
NASDAQ·08/12 20:44
TherapeuticsMD Q2 Earnings Summary
Seeking Alpha·08/12 20:44
Therapeutics MD GAAP EPS of $0.05
Same Industry
Name/Symbol
Change%
Price